Vivos is poised to disrupt the very significant pediatric obstructive sleep apnea (OSA) market with new FDA clearance and new strategic marketing ...

Vivos Therapeutics (NASDAQ: VVOS) , a leading medical-device and technology company specializing in the development and commercialization of highly effective proprietary treatments for sleep-related ...

Schmidt said she spent the next 17 years stuck on a “surgery carousel” with ... Dental splints, the most common TMJ treatment, also known as night guards or mouth guards, are removable dental ...

However, after AT surgery, OSA may relapse or persist in 21% to 73% of ... The Vivos Method (comprised of Vivos' Complete Airway Repositioning and/or Expansion (CARE) and other oral appliance therapy ...

According to the General Accounting Office, 82 percent of American adults have at least one credit card, which enables them to make those larger and sometimes unexpected purchases, like appliances for ...

When it comes to babies, drooling is common and usually considered normal. It is connected to their limited ability to swallow. Even as an adult, you may have experienced your saliva flowing out of ...

In cosmetic surgery and dentistry, ‘plasty’ is used as a suffix in the name of many surgical procedures that are designed to ...

A drug originally developed for epilepsy may offer new hope for individuals struggling with obstructive sleep apnoea, a ...

The effects of the epilepsy drug need further investigation, but it appears to have had positive results on snoring.

But the new GLP-1 weight loss medications, such as Ozempic, Mounjaro or Wegovy, may be used in the future, perhaps in concert with an oral appliance or airway surgery. That’s on the table ...

Introducing artificial intelligence (AI)–powered robots like AMECA into health care comes with potential benefits like ...

Winners of the 2024 Lasker Awards include researchers who discovered and developed GLP-1 agonists, infectious disease ...